ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir.

February 12, 1993

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

In Brief: Murphy To Head Pediatric Oncology Group; DeVita To Receive ACCC Research Award

May 1, 1992

FDA Approves Implant For Breast Reconstruction

July 26, 2013

NCCS Networker Volume 4 Issue 3, Summer 1990

June 13, 1990